DSP Clinical President and Founder Darlene Panzitta to Address 3rd Annual SCOPE Summit for Clinical Ops Executives

DSP executive to discuss how a few strategic changes can improve outsourced clinical research programs for small to mid-size pharmaceutical and device companies

PARSIPPANY, N.J.--(BUSINESS WIRE)--DSP Clinical President and Founder Darlene Panzitta will present on how to better manager projects, budgets and resources for small to mid-size pharmaceutical and device companies at the 3^rd Annual SCOPE Summit for Clinical Ops Executives, February 5-7, the Hyatt Regency Miami, Florida. DSP provides customer-focused, results-driven Contract Research Services for Phase I-IV clinical studies for this untapped market segment.

“Improving Outsourced Project Management for the Neglected Market of Small to Mid-Size Pharmaceutical and Medical Device Companies”

• Presentation: “Improving Outsourced Project Management for the Neglected Market of Small to Mid-Size Pharmaceutical and Medical Device Companies”
• Date & Time: Wednesday, February 6 at 2:45pm
• Track: Clinical Trial Forecasting, Budgeting and Project Management

It is impossible for Project Managers at smaller companies to avoid fire drills, enrollment issues, overspending, and delayed timelines. Darlene’s talk will offer actionable information that enables PMs managing multimillion dollar studies – even with limited time and resources – to anticipate and resolve problems quickly by making a few key changes to the study plan and budget.

Darlene is an award-winning pharmaceutical executive with 17 years’ experience in drug development and clinical trial management. She is an expert in Phase I-IV studies. Her therapeutic expertise includes women’s health, reproductive endocrinology/infertility, urology, pain, CNS, gastrointestinal, gynecology, dermatology, and devices. In 2012 Darlene was named to the PharmaVOICE 100 list of the most influential people in the life sciences industry. She earned a BS in Science and a MS in Biology from Farleigh Dickinson University.

DSP Clinical also will sponsor the SCOPE Summit coffee breaks on Tuesday, February 5.

To schedule a personal meeting with DSP Clinical executives at the SCOPE Summit contact Bill O’Boyle, Executive Director Business Development, [e-mail] 732-917-4500.

About DSP Clinical

DSP Clinical is an award-winning, full service Contract Research Organization (CRO) dedicated to the management and execution of Phase I-IV clinical studies for small to mid-size pharmaceutical and device companies. Since Darlene Panzitta founded DSP Clinical in 1999 the company has earned a reputation for excellence in clinical trial management and customer service. DSP Clinical drives top-tier success for domestic and international studies through unmatched experience, passionate leadership, aggressive strategies, and operational excellence. DSP Clinical’s expertise includes overall project management, study site management, study and site monitoring, data management (including Electronic Data Capture), statistics, medical writing, and FDA submissions. Visit www.dspclinical.com.